Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.516965563491167.6202
Domestic EquitiesDivi's Laboratories Limited9.65261350808833.8133
Domestic EquitiesLupin Limited7.60573203676656.9939
Domestic EquitiesCipla Limited5.50473100000475.5090
Domestic EquitiesApollo Hospitals Enterprise Limited5.1290648795443.0556
Domestic EquitiesDr. Reddy's Laboratories Limited5.09713662170440.3027
Domestic EquitiesVijaya Diagnostic Centre Limited4.08593025298352.9464
Domestic EquitiesAjanta Pharma Limited3.3567959323289.9602
Domestic EquitiesMedPlus Health Services Limited3.22993564680279.0075
Domestic EquitiesGland Pharma Limited3.01801500000260.7000
Domestic EquitiesAbbott India Limited2.772686390239.5025
Domestic EquitiesMankind Pharma Limited2.6656899036230.2611
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.56901278814221.9126
Domestic EquitiesAurobindo Pharma Limited2.48861702630214.9741
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited2.3566832787203.5665
Domestic EquitiesZydus Lifesciences Limited2.23722000632193.2510
Domestic EquitiesNarayana Hrudayalaya Limited2.20141501224190.1600
Domestic EquitiesThyrocare Technologies Limited2.04491765838176.6456
Domestic EquitiesPfizer Limited1.9575318249169.0936
Domestic EquitiesTorrent Pharmaceuticals Limited1.9371503364167.3283
Domestic EquitiesAlkem Laboratories Limited1.8120277412156.5283
Domestic EquitiesFortis Healthcare Limited1.75522300000151.6160
Domestic EquitiesSanofi India Limited1.7035230272147.1553
Domestic EquitiesSyngene International Limited1.22501124795105.8207
Domestic EquitiesOrchid Pharma Limited1.2091623032104.4482
Domestic EquitiesSanofi Consumer Healthcare India Limited1.1935213659103.0990
Domestic EquitiesDr. Lal Path Labs Limited1.005028911286.8174
Domestic EquitiesIndoco Remedies Limited0.6898183492459.5892
Domestic EquitiesHealthcare Global Enterprises Limited0.523790043245.2377
Domestic EquitiesAstraZeneca Pharma India Limited0.48696407842.0621
Domestic EquitiesEmcure Pharmaceuticals Limited0.474130000040.9500
Domestic EquitiesIPCA Laboratories Limited0.425623831136.7607
Domestic EquitiesSuraksha Diagnostic Limited0.405279366235.0005
Domestic EquitiesKrishna Institute Of Medical Sciences Limited0.315246178527.2245
Domestic EquitiesConcord Biotech Limited0.275211173823.7723
Total 96.9259 8372.6860
Cash & Cash Equivalents and Net AssetsTriparty Repo3.2176 277.9459
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0014 0.1195
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.1449 -12.5200
Total 3.0741 265.5454
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.